Management Team

Mr Jean-François Naa was appointed the Chief Executive Officer (CEO) of IHH Healthcare Malaysia on 1 March 2020. He provides the strategic direction and maintains high standards of operational and clinical excellence for IHH’s integrated healthcare businesses in Malaysia, which includes a network of 18 hospitals encompassing Gleneagles Hospitals, Island Hospital, Pantai Hospitals, Prince Court Medical Centre and Timberland Medical Centre, as well as ancillary services such as Premier Integrated Labs and Premier Integrated Rehab.

Mr Jean-François has more than 30 years of experience in the healthcare industry and has held the role of Chief Executive Officer of several IHH Healthcare entities since 2012. He has been the Chief Executive Officer of Gleneagles Hospital Johor and Gleneagles Hospital Kota Kinabalu in Malaysia, Regional Chief Executive Officer of South and East Malaysia and interim Chief Executive Officer of IHH Healthcare India. In Singapore, he was the covering Chief Executive Officer for Gleneagles Hospital Singapore, Deputy Chief Executive Officer for Mount Elizabeth Novena Hospital as well as Chief Executive Officer of Gleneagles Clinical Research Centre.

Mr Jean-François spent the early part of his career in sales and marketing for the pharmaceutical industry in Europe. He joined Novartis Thailand in 2002 as the Oncology Medical Advisor/Clinical Research Manager before being appointed as Head, Global Patient Access, Asia-Pacific for Novartis Oncology. In 2006, he became the General Manager of Novartis Pharmaceuticals to oversee the business in Vietnam and Cambodia. In 2009, Jean-François took on the role of Vice President of Primary Care at Astra Zeneca in Thailand.